Clinical Trials Logo

Clinical Trial Summary

Pyrotinib is an important drug for the treatment of breast cancer, but the incidence of diarrhea is very high. At present, there is no particularly effective drug for diarrhea induced by pyrotinib. Trying to intervene with traditional Chinese medicine may bring better results to patients.


Clinical Trial Description

Pyrotinib is an important drug for the treatment of breast cancer, but the incidence of diarrhea is very high. At present, there is no particularly effective drug for diarrhea induced by pyrotinib. Trying to intervene with traditional Chinese medicine may bring better results to patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04988165
Study type Interventional
Source Tianjin Medical University Cancer Institute and Hospital
Contact zhansheng jiang, doctor
Phone 022-23340123-1101
Email zhjiang@tmu.edu.cn
Status Recruiting
Phase Phase 2
Start date October 8, 2021
Completion date October 8, 2022